understand on-going deal review creat uncertainti view ultim
risk/reward quit posit skew reiter buy rate see current
discount rel histor level broader market wide cash
flow profil meanwhil biggest pushback receiv post-launch address
detail pg concern time uncertainti deal process
question deal also view recent announc cigna-express script
deal solidifi role integr medical/pharmaci provid
view set asset well-posit shift set care compani
roll addit servic store near-term basi view deal
distract associ esrx could also offer addit opportun
garner addit win earli check suggest chang
posit view like acquir thu deliv
messag continu relat pbm contract
takeaway pbm expert call
one area combin cvs-aet could well-posit drive outsiz growth
specialti remain highest growth area within broader drug channel
abil intertwin specialti across pharmacy/med benefit direct
benefit on-going cvs-aet pend merger expert also believ small
employ work small pbm outsourc specialti pharmaci benefit larg
integr specialti payer/pharmaci could attract way manag
cost includ broader takeaway call recap note
tweak ep mix factor
adjust estim recent debt rais current market
environ increas ep estim
respect new estim includ posit flu benefit on-going
invest evolut busi refin view share count
off-set higher interest expens reiter buy rate po
unchang base ep
net dbt
continu earli thought read-
through space
distribut alexa let tri get
back industri fundament
overview feedback
long-term opportun remain place
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one largest healthcar compani
unit state provid retail mail
specialti pharmaci dispens servic
pharmaci benefit upon complet
acquisit aetna would becom one
vertic integr publicli trade
healthcar compani base
buy rate driven transform
vertic integr aetna assum deal
close stabl free cash flow appeal
valuat think compani deal aetna
provid ampl short-term long-term synergi
opportun provid clear way extract
valu retail franchis stabl
free cash flow three busi
allow compani gener outsiz
return equiti next year
market say
bofa merril lynch global research summari understand
questions/uncertainti creat stock current go review process
think ultim opportun total cash flow generation/earn power
meaning over-discount current level reiter buy rate po
februari reinstat coverag highlight view
pro forma entiti abil shift way care deliv particularli
reposit part store healthcar provid set given
minuteclin provid solid base footprint mention remaind
store expand joint compani healthcar servic offer assum
deal goe would also leverag integr pharmacy/med care
would well-align drive total cost system
holist view individu area optum
subsidiari taken lead power joint cvs-aet
capabl creat uniqu offer
gener rel agreement opportun entiti
howev want highlight sourc feedback/deb occur
uncertainti aetna-humana anthem-cigna deal
creat stock meaning under-perform market
right deal offici announc end right
deal offici termin four deal stock averag stock declin
around vs almost gain involv investor
wari repeat particularli two larg healthcar servic deal
review follow cigna-express script announc
vertic integr deal cvs-aet appear straightforward
uncertainti around depart justic review process creat time question
current statu doj current full complement
member leav reduc clariti current member may focus
come review deal issu aros aetna-
anthem-cigna deal fairli recent rear-view mirror creat anoth
time element need laps
combin potenti interest expens
potenti evolut combin cvs-aet envis new
healthcar total cost manag model expand success unh/optum
howev reposit store take time well invest busi
estim current minuteclin footprint within averag store
sq ft averag sq ft store everi addit piec store
need healthcar servic cost money reposit well creat
opportun cost addit lost revenu tradit retail item front-
end pharmaci detail view current minuteclin base pg
reinstat coverag
defens natur deal simpli delay amazon risk
firmli believ event amazon pharmaci never enter
discuss transact would view offens maneuv design
address rise healthcar cost instead deal take len defens move
vs potenti risk amazon mayb enter market view
matter us call deal sinc believ merit deal
creat increas barrier entri vs amazon new entrant risk even better
fulli acknowledg industri fundament year
ago gener adopt much lower number industri profit
tailwind remain place said still think abil
gener sustain low/mid-singl digit ebit growth well increment
contribut capit deploy view way reflect
current discount histor level absolut basi rel
exhibit closer histor correl vs meaning de-coupl sinc current trade widest discount
